Bio Medica Laboratories IPO Date, Review, Price, Allotment Details

Bio Medica Laboratories IPO open date is May 21, 2026 and the IPO will close on May 25, 2026. Bio Medica Laboratories IPO is a Book build Issue. The company to raise around ₹[.] crores via IPO that comprises fresh issue of ₹[.] crores and offer for sale up to 3,76,800 equity shares with face value of ₹10 each.

Bio Medica Laboratories IPO price band is ₹[.] to ₹[.] per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. Bio Medica Laboratories IPO to list on NSE on May 28, 2026. The allotment of Bio Medica Laboratories IPO date is May 26, 2026.

The company reported revenue of ₹38.33 crores in 2025 against ₹15.34 crores in 2024. The company reported profit of ₹9.79 crores in 2025 against profit of ₹2.50 crores in 2024. As per the financials the IPO investors should apply the IPO for a long term.

Bio Medica Laboratories IPO

Bio Medica Laboratories IPO Details

IPO Open DateMay 21, 2026
IPO Close DateMay 25, 2026
Face Value₹10 Per Equity Share
IPO Price Band₹[.] to ₹[.] Per Share
Issue SizeApprox ₹[.] Crores, 37,71,600 Equity Shares
Fresh IssueApprox ₹[.] Crores, 33,95,00 Equity Shares
Offer for Sale:Approx 3,76,800 Equity Shares
Issue TypeBook build Issue
IPO ListingNSE SME
DRHP Draft ProspectusPDF
RHP Draft ProspectusPDF

Bio Medica Laboratories IPO Review & Key Points

  • Review:

Bio Medica Laboratories IPO Market Lot

The Bio Medica Laboratories IPO minimum market lot is [.] shares with ₹[.] application amount. The retail investors can apply up-to 13 lots with [.] shares of ₹[.] amount.

ApplicationLot SizeSharesAmount
Retail Minimum₹-
Retail Maximum₹-
S-HNI Minimum₹-
S-HNI Maximum₹-
B-HNI Minimum₹-

IPO Reservation

Investor CategoryShare Offered Shares (%)
Anchor Investor– Shares-%
QIB (Ex. Anchor)– Shares50%
NII Shares Offered– Shares15%
Retail Shares Offered– Shares35%

Bio Medica Laboratories IPO Dates

The Bio Medica Laboratories IPO date is May 21 and the close date is May 25. The Bio Medica Laboratories IPO allotment will be finalized on May 26 and the IPO listing on May 28.

IPO Open Date:May 21, 2026
IPO Close Date:May 25, 2026
Basis of Allotment:May 26, 2026
Refunds:May 27, 2026
Credit to Demat Account:May 27, 2026
IPO Listing Date:May 28, 2026
IPO Bidding Cut-off Time:May 25, 2026 – 5 PM

Promoters and Holding Pattern

The promoters of the company are Mr. Mukesh Mehta and Mr. Pradeep Mehta.

ParticularShares% Share
Promoter Holding Pre Issue91,80,00199.99%
Promoter Holding Post Issue1,25,74,801-%

Objects of the Issue & Utilisation of Proceeds

PurposeCrores
Repayment of Loan₹7.25
Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises₹24.81
General Corporate Purpose₹-

About Bio Medica Laboratories IPO

To be updated soon

Bio Medica Laboratories IPO Company Financial Report

Amount ₹ in Crores

Period EndedRevenueExpensePATAssets
2023₹16.25₹15.80₹0.33₹17.57
2024₹15.34₹11.69₹2.50₹19.53
2025₹38.33₹25.18₹9.79₹39.12
Nov 2025₹28.63₹16.95₹8.66₹65.17

Bio Medica Laboratories IPO Valuation – FY2025

Check Bio Medica Laboratories IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.

KPIValues
ROE:99.59%
ROCE:48.20%
EBITDA Margin:39.83%
PAT Margin:25.64%
Debt to equity ratio: 1.02
Earning Per Share (EPS):₹10.67 (Basic)
Price/Earning P/E Ratio:N/A
Return on Net Worth (RoNW):99.59%
Net Asset Value (NAV):₹16.05

Peer Group Comparison

CompanyEPSPE RatioRoNW %NAVIncome
Zenotech Laboratories Limited0.926.01%15.765.61 Cr.
Shukra Pharmaceuticals Limited0.2247.5715.90%1.439.58 Cr.

IPO Lead Managers aka Merchant Bankers

  • Narnolia Financial Services Ltd.Ā 

Company Address

Bio Medica Laboratories Ltd.
Plot No. 11B-11C, Sector-E, Sanwer Road
Industrial Area, Industrial Estate (Indore),
Indore, Madhya Pradesh, 452015
Phone: +91 7314102751
Email: companysecretary@biomedica.co.in
Website: http://www.biomedica.co.in/

IPO Registrar

Skyline Financial Services Pvt.Ltd.
Phone: 02228511022
Email: ipo@skylinerta.com
Website: https://www.skylinerta.com/ipo.php

Bio Medica Laboratories IPO FAQs

What is Bio Medica Laboratories IPO?

Bio Medica Laboratories IPO is SME IPO. The company is going to raise ₹[.] Crores via IPO. The issue is priced at ₹[.] to ₹[.] per equity share. The IPO is to be listed on NSE.

When Bio Medica Laboratories IPO will open for subscription?

The IPO is to open on May 21, 2026 for QIB, NII, and Retail Investors. The IPO will close on May 25, 2026.

What is Bio Medica Laboratories IPO Investors Portion?

The investors’ portion for QIB is 50%, NII is 15%, and Retail is 35%.

How to Apply the Bio Medica Laboratories IPO?

You can apply for Bio Medica Laboratories IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.

What is Bio Medica Laboratories IPO Issue Size?

Bio Medica Laboratories IPO issue size is ₹[.] crores.

What is Bio Medica Laboratories IPO Price Band?

Bio Medica Laboratories IPO Price Band is ā‚¹[.] to ₹[.].

What is Bio Medica Laboratories IPO Lot Size?

The minimum bid is [.] Shares with ₹[.] amount.

What is the Bio Medica Laboratories IPO Allotment Date?

Bio Medica Laboratories IPO allotment date is May 26, 2026.

What is the Bio Medica Laboratories IPO Listing Date?

Bio Medica Laboratories IPO listing date is May 28, 2026. The IPO is to list on NSE.

Note: The Bio Medica Laboratories IPO price band and date are officially announced. The (Bio Medica Laboratories IPO grey market premium) will be added to the IPO GMP page as it will start).

Table of Contents

Picture of Jagat Joshi

Jagat Joshi

Founder of IPOWatch, brings nearly 15 years of experience in IPO analysis and market research. He provides complete coverage of upcoming IPOs, subscription trends, grey market premiums (GMP), and post-listing performance, along with easy-to-understand reviews, insights, and analysis. In his working journey, he has worked with various platforms and received expertise in stock market analysis and primary markets.
Picture of Jagat Joshi

Jagat Joshi

Leave a Reply

Your email address will not be published. Required fields are marked *